Citigroup
CRTX

Citigroup’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

Citigroup’s Portfolio CRTX Stock Details CRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-6,980
Closed -$66K – 7464
2013
Q4 		$66K Sell
6,980
-2,865
-29% -$27.1K ﹤0.01% 5563
2013
Q3 		$93K Buy
9,845
+5,985
+155% +$53.9K ﹤0.01% 4790
2013
Q2 		$31K Buy
+3,860
New +$32.5K ﹤0.01% 5629

Other funds holding CRTX

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Citigroup's CRTX Position: Q1 2014 in Review

Citigroup sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q1 2014, closing a stake of 6,980 shares — an estimated $66K sold.

Citigroup first reported a position in CRTX in Q2 2013 and held it in 3 quarters. The position peaked at $93K in Q3 2013. 1 fund tracked by Wall St. Rank holds CRTX as of Q1 2014.

  • Citigroup reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q1 2014 after selling out during the quarter.
  • Citigroup sold 6,980 CORNERSTONE THERAPEUTICS INC shares in Q1 2014, an estimated $66K.
  • Citigroup first reported a position in CORNERSTONE THERAPEUTICS INC in Q2 2013 and held it in 3 quarters.
  • Citigroup's CORNERSTONE THERAPEUTICS INC position peaked at $93K in Q3 2013.
  • 1 fund tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q1 2014.

Based on Citigroup's 13F filing for Q1 2014, filed 15 May 2014.